225 related articles for article (PubMed ID: 32964521)
21. UVB in the management of early stage mycosis fungoides.
Pavlotsky F; Barzilai A; Kasem R; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2006 May; 20(5):565-72. PubMed ID: 16684285
[TBL] [Abstract][Full Text] [Related]
22. Phototherapy of Mycosis Fungoides.
Hodak E; Pavlovsky L
Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
[TBL] [Abstract][Full Text] [Related]
23. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
[TBL] [Abstract][Full Text] [Related]
24. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
D'Acunto C; Gurioli C; Neri I
J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
[TBL] [Abstract][Full Text] [Related]
25. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study.
Diederen PV; van Weelden H; Sanders CJ; Toonstra J; van Vloten WA
J Am Acad Dermatol; 2003 Feb; 48(2):215-9. PubMed ID: 12582391
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
[TBL] [Abstract][Full Text] [Related]
27. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides.
Boztepe G; Sahin S; Ayhan M; Erkin G; Kilemen F
J Am Acad Dermatol; 2005 Aug; 53(2):242-6. PubMed ID: 16021117
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.
Vieyra-Garcia P; Fink-Puches R; Porkert S; Lang R; Pöchlauer S; Ratzinger G; Tanew A; Selhofer S; Paul-Gunther S; Hofer A; Gruber-Wackernagel A; Legat F; Patra V; Quehenberger F; Cerroni L; Clark R; Wolf P
JAMA Dermatol; 2019 May; 155(5):538-547. PubMed ID: 30892603
[TBL] [Abstract][Full Text] [Related]
29. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy.
Laws PM; Shear NH; Pope E
Pediatr Dermatol; 2014; 31(4):459-64. PubMed ID: 24916067
[TBL] [Abstract][Full Text] [Related]
30. NB-UVB (311-312 nm)-induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy.
Friedland R; David M; Feinmesser M; Barzilai A; Hodak E
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1158-62. PubMed ID: 21790796
[TBL] [Abstract][Full Text] [Related]
31. Phototherapy for hypopigmented mycosis fungoides in Asians.
Wongpraparut C; Setabutra P
Photodermatol Photoimmunol Photomed; 2012 Aug; 28(4):181-6. PubMed ID: 23017170
[TBL] [Abstract][Full Text] [Related]
32. Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States.
Xia FD; Ferket BS; Huang V; Stern RS; Wu PA
J Am Acad Dermatol; 2019 Feb; 80(2):485-492.e4. PubMed ID: 30081119
[TBL] [Abstract][Full Text] [Related]
33. Effect of PUVA and NB-UVB Therapy on the Skin Cytokine Profile in Patients with Mycosis Fungoides.
Karamova AE; Verbenko DA; Vorontsova AA; Zhilova MB; Nikonorov AA; Gatiatulina ER; Znamenskaya LF; Kubanov AA
J Oncol; 2022; 2022():3149293. PubMed ID: 35237320
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of narrow-band ultraviolet-B therapy in patch-stage mycosis fungoides: A clinical study and review of the literature.
Atci T; Baykal C
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):271-277. PubMed ID: 32145109
[TBL] [Abstract][Full Text] [Related]
35. The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides.
Hoot JW; Wang L; Kho T; Akilov OE
J Dermatolog Treat; 2018 May; 29(3):272-276. PubMed ID: 28782389
[TBL] [Abstract][Full Text] [Related]
36. Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
[TBL] [Abstract][Full Text] [Related]
37. [Narrow band UVB therapy in early stage mycosis fungoides. A study of 23 patients].
Coronel-Pérez IM; Carrizosa-Esquivel AM; Camacho-Martínez F
Actas Dermosifiliogr; 2007 May; 98(4):259-64. PubMed ID: 17506957
[TBL] [Abstract][Full Text] [Related]
38. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients.
Ghodsi SZ; Hallaji Z; Balighi K; Safar F; Chams-Davatchi C
Clin Exp Dermatol; 2005 Jul; 30(4):376-8. PubMed ID: 15953074
[TBL] [Abstract][Full Text] [Related]
39. The use of interferon-α2a as monotherapy in stage IB patients with mycosis fungoides: A retrospective chart review of patient outcomes.
Gökşin Ş; İmren IG; Cenk H; Kaçar N; Duygulu Ş
Dermatol Ther; 2022 Apr; 35(4):e15344. PubMed ID: 35094466
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
